eMedicine Specialties > Emergency Medicine > Environmental

Spider Envenomation, Funnel Web

Author: Joe Alcock, MD, MS, Assistant Professor, Department of Emergency Medicine, University of New Mexico Health Sciences Center; Acting Chief, Emergency Medicine Service, New Mexico Veterans Affairs Health Care System
Contributor Information and Disclosures

Updated: Dec 4, 2008

Introduction

Background

Australian funnel-web spiders (family Hexathelidae, subfamily Atracinae, genera Atrax and Hadronyche) are the most venomous spiders in the world based on clinical experience in Australia and animal lethal dose studies. Funnel-web spiders belong to the suborder Mygalomorphae, a primitive group of spiders that also includes tarantulas. Funnel-web spiders of medical importance comprise 40 species within 2 genera, Atrax and Hadronyche, in the family Hexathelidae, subfamily Atracinae. The Atrax genus contains 3 species, including Atrax robustus, the Sydney funnel-web spider. The remaining 37 species are members of the genus Hadronyche. Funnel-web spiders are primarily found on the eastern coast of Australia. Related funnel-web spiders can also be found in New Guinea and the Solomon Islands.

Funnel-web spiders are medium-to-large robust spiders that tend to be dark or black in color. These spiders measure up to 5 cm. They have stout legs and prominent fang-bearing chelicerae that deliver a neurotoxic venom. The common name derives from the funnel-like entrance to silk-lined subterranean burrows built by both males and females. The Sydney funnel-web spider (A robustus) is responsible for most reported envenomations and the only confirmed deaths in humans.

The Sydney funnel-web spider, <EM>Atrax robustus<...

The Sydney funnel-web spider, Atrax robustus. Male (left) and female (right). Photograph courtesy of the Australian Venom Research Unit, Department of Pharmacology, University of Melbourne, Australia.

The Sydney funnel-web spider, <EM>Atrax robustus<...

The Sydney funnel-web spider, Atrax robustus. Male (left) and female (right). Photograph courtesy of the Australian Venom Research Unit, Department of Pharmacology, University of Melbourne, Australia.


However, bites from other funnel-web spiders, particularly the northern tree spider, Hadronyche formidabilis, are likely to cause serious envenomation syndromes and are potentially deadly if untreated.

In Australia, there have been 138 confirmed funnel-web spider bites since 1926 to 2004.1 A prospective study revealed 16 envenomations between 1999 and 2003;2 10-20% of bites produce toxicity. Male spiders are responsible for most bites. Unfortunately, the venom of male spiders is also more toxic than that of female spiders. Male funnel-web spiders exhibit a seasonal wandering behavior in search of female mates, which often brings them into houses and in contact with humans. Humans and other primates suffer severe life-threatening toxicity from the venom, while other vertebrates, such as rabbits and cats, are almost unaffected. Since 1981 when an antivenom was first used clinically, no fatalities have occurred.

Pathophysiology

The venom components responsible for mortality and morbidity are labeled delta-atracotoxins (formerly robustotoxin in A robustus and versutoxin in Hadronyche versuta). While the amino acid structure of delta-atracotoxins differs slightly between species of funnel-web spiders, strong antigenic cross-reactivity exists between their venoms. Funnel-web spider antivenom, derived from purified immunoglobulin G (IgG) of rabbits hyperimmunized with A robustus venom , is also effective against venom of Hadronyche species. Delta-atracotoxins are polypeptide neurotoxins that induce spontaneous, repetitive firing and prolongation of action potentials in presynaptic autonomic and motor neurons. 

Delta-atracotoxins bind to the outer surface of tetrodotoxin-sensitive sodium channels. After binding, they induce excitability of these voltage-dependent sodium channels. The toxins also interfere with the conformational changes necessary for gating and inactivation of the channel. The ensuing massive neurotransmitter release results in an autonomic storm. The excessive release of endogenous acetylcholine, norepinephrine, and epinephrine is responsible for many of the clinical findings of funnel-web spider envenomation.

Envenomation is heralded by substantial pain at the bite site. Most funnel-web spider bites do not proceed to severe systemic symptoms, causing only mild or local neurotoxic effects. In severe cases, the onset of symptoms is rapid, with a median onset of 28 minutes. Agitation and vomiting are common. Autonomic effects include diaphoresis, salivation, piloerection, lacrimation, and pupillary changes. Cardiovascular changes commonly include hypertension and tachycardia. Hypotension and bradycardia occur more rarely. Pulmonary edema occurs in more than half of severe envenomations, with dyspnea and pink, frothy sputum often accompanied by respiratory failure. Skeletal muscle fasciculation, muscle spasms, and oral paresthesias are frequent neurologic findings. Coma or loss of consciousness occurs in about 10% of patients who experience severe envenomation.

Rhabdomyolysis is common in serious envenomation with massive increases in serum creatine kinase (CK) levels and risk of renal failure.

Frequency

International

Funnel-web spiders of medical importance are found in eastern and southern Australia. The Sydney funnel-web spider (A robustus) is distributed in a roughly 75-mile radius around the city of Sydney. Hadronyche species have a much wider distribution, from southeast Queensland to Victoria, Tasmania, and parts of South Australia.

Sixteen confirmed cases of funnel-web spider bites were reported to poison control centers or hospitals in Australia from 1999-2003. A minority of patients (10-20%) require treatment with antivenom.2

Mortality/Morbidity

  • The mortality rate is difficult to determine from data from the era before antivenom. From 1927-1980, 13 deaths attributed to A robustus were reported in the medical literature and news media. No deaths have occurred since the introduction of antivenom.1
  • Deaths occurred in children and adult females with bites. In all cases where the spider was identified, the culprit was the Sydney funnel-web spider, A robustus. Severe envenomation, but not death, has been reported following bites by Hadronyche species.
  • Death occurs between 15 minutes and 3 days following the bite. In children, death is usually early and caused by pulmonary edema. In adults, death usually occurs later and is caused by persistent hypotension and cardiovascular collapse. In the late 1970s, two deaths occurred despite modern intensive care units. Death in these cases occurred from multisystem organ failure days after the bite.3

Age

Bites are equally common in adults and children. However, envenomation in children is more severe because of the greater venom load per kilogram of body mass. Children may experience life-threatening envenomation within an hour of the bite and require immediate treatment.

Clinical

History

  • The spider usually is seen, and its bite is extremely painful for hours to days (the fangs are large and enter with considerable force).
  • Early symptoms of systemic envenomation may occur rapidly, with a 28-minute median onset. A pressure-immobilization dressing can delay onset of symptoms.
  • The following are symptoms of a serious envenomation:

    • Perioral tingling
    • Lacrimation
    • Salivation
    • Abdominal pain
    • Nausea
    • Vomiting
    • Diaphoresis
    • Severe dyspnea
  • Muscle fasciculations and spasms are common.
  • Agitation and confusion can occur.
  • Unconsciousness occurs in a minority of patients.

Physical

  • Erythema, piloerection, diaphoresis, and muscle fasciculation may be seen at and around the bite site.
  • Generalized diaphoresis, lacrimation, and salivation may be noted.
  • Fasciculations and muscle spasms are frequent findings in severe envenomation; however, paralysis does not appear to occur.
  • A brief period of hypotension and tachycardia is followed by severe hypertension.
  • Cardiac arrhythmias and cardiac arrest may occur.
  • Severe pulmonary edema that is poorly responsive to loop diuretics occurs early and may be fatal.

More on Spider Envenomation, Funnel Web

Overview: Spider Envenomation, Funnel Web
Differential Diagnoses & Workup: Spider Envenomation, Funnel Web
Treatment & Medication: Spider Envenomation, Funnel Web
Follow-up: Spider Envenomation, Funnel Web
Multimedia: Spider Envenomation, Funnel Web
References

References

  1. Isbister GK, Gray MR, Balit CR, Raven RJ, Stokes BJ, Porges K, et al. Funnel-web spider bite: a systematic review of recorded clinical cases. Med J Aust. Apr 18 2005;182(8):407-411. [Medline][Full Text].

  2. Isbister GK, Gray MR. Bites by Australian mygalomorph spiders (Araneae, Mygalomorphae), including funnel-web spiders (Atracinae) and mouse spiders (Actinopodidae: Missulena spp). Toxicon. 2004;43(2):133-40. [Medline].

  3. Fisher MM, Carr GA, McGuinness R, Warden JC. Atrax robustus envenomation. Anaesth Intensive Care. Nov 1980;8(4):410-20. [Medline].

  4. Dieckmann J, Prebble J, McDonogh A, Sara A, Fisher M. Efficacy of funnel-web spider antivenom in human envenomation by Hadronyche species. Med J Aust. Dec 4-18 1989;151(11-12):706-7. [Medline].

  5. Harrington AP, Raven RJ, Bowe PC, Hawdon GM, Winkel KD. Funnel-web spider (Hadronyche infensa) envenomations in coastal south-east Queensland. Med J Aust Med J Aust. Dec 6-20 1999;171(11-12):651-3. [Medline][Full Text].

  6. Howarth DM, Southee AE, Whyte IM. Lymphatic flow rates and first-aid in simulated peripheral snake or spider envenomation. Med J Aust. Dec 5-19 1994;161(11-12):695-700. [Medline].

  7. Sutherland SK. The Sydney funnel-web spider (Atrax robustus). 3. A review of some clinical records of human envenomation. Med J Aust. 1972;2:642-6.

  8. Sutherland SK, Duncan AW. New first-aid measures for envenomation: with special reference to bites by the Sydney funnel-web spider (Atrax robustus). Med J Aust. Apr 19 1980;1(8):378-9. [Medline].

  9. Sutherland SK, Duncan AW, Tibballs J. Local inactivation of funnel-web spider (Atrax robustus) venom by first- aid measures: potentially lifesaving part of treatment. Med J Aust. Oct 18 1980;2(8):435-7. [Medline].

  10. White J, Cardoso JL, Fan HW. Clinical toxicology of spider bites. In: Handbook of Clinical Toxicology of Animal Venoms and Poisons. CRC Press; 1995:272-83.

Further Reading

Keywords

funnel-web spider, funnel web spider, Sydney funnel web spider, spider bite treatment, spider bite symptoms, Atrax, Hadronyche, Atrax robustus, Hadronyche versuta, Hexathelidae, spider envenomation, spider bite, Australian funnel-web spider, delta-atracotoxins, robustotoxin, antivenom

Contributor Information and Disclosures

Author

Joe Alcock, MD, MS, Assistant Professor, Department of Emergency Medicine, University of New Mexico Health Sciences Center; Acting Chief, Emergency Medicine Service, New Mexico Veterans Affairs Health Care System
Joe Alcock, MD, MS is a member of the following medical societies: American Academy of Emergency Medicine
Disclosure: Nothing to disclose.

Medical Editor

Robert L Norris, MD, Associate Professor, Department of Surgery; Chief, Division of Emergency Medicine, Stanford University Medical Center
Robert L Norris, MD is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, California Medical Association, International Society of Toxinology, Society for Academic Emergency Medicine, and Wilderness Medical Society
Disclosure: Nothing to disclose.

Pharmacy Editor

John T VanDeVoort, PharmD, Regional Director of Pharmacy, Sacred Heart & St. Joseph's Hospitals
John T VanDeVoort, PharmD is a member of the following medical societies: American Society of Health-System Pharmacists
Disclosure: Nothing to disclose.

Managing Editor

Matthew M Rice, MD, JD, FACEP, Senior Vice President, Chief Medical Officer, Northwest Emergency Physicians; Assistant Clinical Professor of Medicine, University of Washington at Seattle
Matthew M Rice, MD, JD, FACEP is a member of the following medical societies: American College of Emergency Physicians, American Medical Association, National Association of EMS Physicians, Society for Academic Emergency Medicine, and Washington State Medical Association
Disclosure: Team Health  Salary Employment

CME Editor

John D Halamka, MD, MS, Associate Professor of Medicine, Harvard Medical School, Beth Israel Deaconess Medical Center; Chief Information Officer, CareGroup Healthcare System and Harvard Medical School; Attending Physician, Division of Emergency Medicine, Beth Israel Deaconess Medical Center
John D Halamka, MD, MS is a member of the following medical societies: American College of Emergency Physicians, American Medical Informatics Association, Phi Beta Kappa, and Society for Academic Emergency Medicine
Disclosure: Nothing to disclose.

Chief Editor

Jonathan Adler, MD, Attending Physician, Department of Emergency Medicine, Massachusetts General Hospital; Division of Emergency Medicine, Harvard Medical School
Jonathan Adler, MD is a member of the following medical societies: American Academy of Emergency Medicine and Society for Academic Emergency Medicine
Disclosure: eMedicine.com, Inc. Consulting fee Consulting

 
 
HONcode

We subscribe to the
HONcode principles of the
Health On the Net Foundation

All material on this website is protected by copyright, Copyright© 1994- by Medscape.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.